- Home
- ELTX vs AKA Comparison
ELTX vs AKA Comparison
Compare ELTX & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- AKA
- Stock Information
- Founded
- ELTX 2011
- AKA 2018
- Country
- ELTX United States
- AKA United States
- Employees
- ELTX N/A
- AKA N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- AKA Catalog/Specialty Distribution
- Sector
- ELTX Health Care
- AKA Consumer Discretionary
- Exchange
- ELTX Nasdaq
- AKA Nasdaq
- Market Cap
- ELTX 121.7M
- AKA 126.7M
- IPO Year
- ELTX N/A
- AKA 2021
- Fundamental
- Price
- ELTX $6.97
- AKA $11.71
- Analyst Decision
- ELTX Strong Buy
- AKA Buy
- Analyst Count
- ELTX 2
- AKA 4
- Target Price
- ELTX $9.50
- AKA $22.50
- AVG Volume (30 Days)
- ELTX 34.8K
- AKA 19.5K
- Earning Date
- ELTX 05-13-2025
- AKA 05-13-2025
- Dividend Yield
- ELTX N/A
- AKA N/A
- EPS Growth
- ELTX N/A
- AKA N/A
- EPS
- ELTX N/A
- AKA N/A
- Revenue
- ELTX N/A
- AKA $586,514,000.00
- Revenue This Year
- ELTX N/A
- AKA $6.62
- Revenue Next Year
- ELTX N/A
- AKA $4.15
- P/E Ratio
- ELTX N/A
- AKA N/A
- Revenue Growth
- ELTX N/A
- AKA 8.09
- 52 Week Low
- ELTX $3.34
- AKA $7.00
- 52 Week High
- ELTX $9.99
- AKA $32.25
- Technical
- Relative Strength Index (RSI)
- ELTX 64.39
- AKA 52.55
- Support Level
- ELTX $6.91
- AKA $12.07
- Resistance Level
- ELTX $7.94
- AKA $12.91
- Average True Range (ATR)
- ELTX 0.50
- AKA 1.02
- MACD
- ELTX 0.25
- AKA 0.03
- Stochastic Oscillator
- ELTX 73.12
- AKA 47.10
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.